We share data on 50 high-growth "pandemic darlings" that have sold off extremely hard, and with a special focus on Palantir. We go into the details on Palantir positives and negatives (including TAM, growth, leadership, products, margins, profits, valuation, government versus commercial, share-based compensation, dilution, and industrywide challenges).
Palantir: 50 Hated Pandemic Stocks, These 3 Worth Considering